Analytical Champions: Sarah O’Keeffe
November 10, 2026
Eli Lilly’s Sarah O’Keeffe reflects on leadership, collaboration, and the analytical advances helping bring increasingly complex medicines to patients
14 min read
False
Advertisement
Top Stories
Browse By Topic
Newsletters
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.
Voices in the Community
The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.
Bruce Levine
Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania Perelman School of Medicine
View ProfileMusings from The Power List: Claudia Zylberberg
Claudia Zylberberg discusses building the infrastructure, partnerships, and policies needed to bring advanced therapies to patients at scale
Latest News
All the latest Medicine Maker articles.
Scaling CRISPR Gene Correction for Sickle Cell Disease
November 9, 2026
Researchers establish a clinical-scale, nonviral manufacturing process that directly repairs the disease-causing HBB mutation in autologous stem cells
2 min read
Is Pharma Building the Right Facilities for Future Biologics?
November 9, 2026
As biologics portfolios expand and average product volumes fall, Miriam Monge asks whether today’s major manufacturing investments offer the flexibility tomorrow’s market will require
5 min read
Video: The Ultimate in Translational Medicine – with Harold Keer
November 6, 2026
Power List 2026 honoree Harold Keer traces oncology’s transformation – and considers what it will take to turn today’s “abundance of riches” into better patient outcomes
1 min read
Preparing Community Hospitals for CAR T’s Expansion
November 5, 2026
By choosing where to participate and working with specialist partners, community hospitals can bring more of the CAR T patient journey closer to home
6 min read
Naive-Like T Cells Linked to CAR T Durability
November 4, 2026
Higher proportions of less-differentiated T cells were associated with longer progression-free survival in a 783-patient lymphoma analysis
1 min read
Who Funds Biotech Shapes What Gets Built
November 4, 2026
Stella Vnook explains why broader representation at the investment table can strengthen biotech, expand support for women-led companies, and accelerate innovation in women’s health
9 min read
Putting Patients in Control of Self-Injection
November 4, 2026
West Pharmaceutical Services’ Whitney Winters discusses how injection device design can support patient comfort, confidence, and independence
5 min read
BMS Details Patient Death in Zola-Cel Multiple Sclerosis Trial
November 3, 2026
The company also reported early efficacy and safety data from the Phase I Breakfree-2 study
2 min read
America Votes, China Plans
November 3, 2026
China sets out its stall for global biopharmaceutical preeminence as the US faces further uncertainty over research funding and regulation
23 min read
Can Immunopeptidomics Redefine Cancer Immunotherapy Development?
November 3, 2026
Immunopeptidomics is helping researchers identify tumor-presented antigens that could inform the development of targeted cell therapies and personalized cancer vaccines
3 min read
Newsletters
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.